• レポートコード:MRC2-11QY04891 • 出版社/出版日:QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、97ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:ヘルスケア |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Multi User | ¥877,500 (USD5,850) | ▷ お問い合わせ |
Enterprise License | ¥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は移植のグローバル市場について調査・分析したレポートです。種類別(腎臓移植、肝移植、心臓移植、肺移植、膵臓移植)市場規模、用途別(病院および移植センター、診断レジストリおよび研究所)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別移植の競争状況、市場シェア ・世界の移植市場:種類別市場規模 2015年-2020年(腎臓移植、肝移植、心臓移植、肺移植、膵臓移植) ・世界の移植市場:種類別市場規模予測 2021年-2026年(腎臓移植、肝移植、心臓移植、肺移植、膵臓移植) ・世界の移植市場:用途別市場規模 2015年-2020年(病院および移植センター、診断レジストリおよび研究所) ・世界の移植市場:用途別市場規模予測 2021年-2026年(病院および移植センター、診断レジストリおよび研究所) ・北米の移植市場分析:米国、カナダ ・ヨーロッパの移植市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの移植市場分析:日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の移植市場分析:メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの移植市場分析:トルコ、サウジアラビア、UAE等 ・企業情報(企業概要、製品概要、販売量、企業動向) - 掲載企業(変更可能性あり):AbbVie、Arthrex、Zimmer Biomet、Medtronic、Novartis、Stryker、BioLifeSolutions、Teva Pharmaceuticals、Veloxis Pharmaceuticals ・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Transplantation is a procedure wherein diseased or injured cells, tissues, or organs are replaced with healthy cells, tissues, or organs to restore normal functioning of the body. Donor and recipient cells, tissues, and organs should match or be compatible, or can lead to transplant rejection. The surface of the transplanted organs contains antigens, which the recipient’s immune system may not adapt to. This can lead to rejection of an organ. Hence, serological and human leukocyte antigen (HLAs) tests are conducted to help identify the antigens and help in successful organ transplantation. With HLA testing, immunosuppressive drugs are provided to minimize graft rejection. In humans, major histocompatibility complex controlled by the genes located on chromosome 6 is responsible for ensuring compatibility between donors and recipients.
M&A between small specialized hospitals and Tier-1 hospitals is one of the primary drivers for market growth. Rising acquisition of small hospitals by large tier-1 hospitals has led to the betterment of organ transplantation, wound care, and diagnosis that has indirectly impacted the growth of the transplantation market positively. These acquisitions assist in training the healthcare staff, including physicians and nurses, and patients are open to avail a range of patient monitoring equipment. Moreover, the brand name of the large hospitals attracts people to receive healthcare services that increase the requirement for transplant diagnostic products, assays, and kits. Also, M&A of small and medium-sized hospitals with large hospitals has increased the availability of services such as dedicated treatments for nephrology and cardiology, which in turn, meets the demands of patients.
Market Analysis and Insights: Global Transplantation Market
The global Transplantation market size is projected to reach US$ 73000 million by 2026, from US$ 65780 million in 2020, at a CAGR of 9.8%% during 2021-2026.
Global Transplantation Scope and Market Size
Transplantation market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Transplantation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AbbVie
Arthrex
Zimmer Biomet
Medtronic
Novartis
Stryker
BioLifeSolutions
Teva Pharmaceuticals
Veloxis Pharmaceuticals
Market segment by Type, the product can be split into
Kidney Transplantation
Liver Transplantation
Heart Transplantation
Lung Transplantation
Pancreas Transplantation
Market segment by Application, split into
Hospitals and Transplant Centers
Diagnostic Registries and Research Laboratories
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Transplantation Revenue
1.4 Market by Type
1.4.1 Global Transplantation Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Kidney Transplantation
1.4.3 Liver Transplantation
1.4.4 Heart Transplantation
1.4.5 Lung Transplantation
1.4.6 Pancreas Transplantation
1.5 Market by Application
1.5.1 Global Transplantation Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Transplant Centers
1.5.3 Diagnostic Registries and Research Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Transplantation Market Perspective (2015-2026)
2.2 Global Transplantation Growth Trends by Regions
2.2.1 Transplantation Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Transplantation Historic Market Share by Regions (2015-2020)
2.2.3 Transplantation Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Transplantation Market Growth Strategy
2.3.6 Primary Interviews with Key Transplantation Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Transplantation Players by Market Size
3.1.1 Global Top Transplantation Players by Revenue (2015-2020)
3.1.2 Global Transplantation Revenue Market Share by Players (2015-2020)
3.1.3 Global Transplantation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Transplantation Market Concentration Ratio
3.2.1 Global Transplantation Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Transplantation Revenue in 2019
3.3 Transplantation Key Players Head office and Area Served
3.4 Key Players Transplantation Product Solution and Service
3.5 Date of Enter into Transplantation Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Transplantation Historic Market Size by Type (2015-2020)
4.2 Global Transplantation Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Transplantation Market Size by Application (2015-2020)
5.2 Global Transplantation Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Transplantation Market Size (2015-2020)
6.2 Transplantation Key Players in North America (2019-2020)
6.3 North America Transplantation Market Size by Type (2015-2020)
6.4 North America Transplantation Market Size by Application (2015-2020)
7 Europe
7.1 Europe Transplantation Market Size (2015-2020)
7.2 Transplantation Key Players in Europe (2019-2020)
7.3 Europe Transplantation Market Size by Type (2015-2020)
7.4 Europe Transplantation Market Size by Application (2015-2020)
8 China
8.1 China Transplantation Market Size (2015-2020)
8.2 Transplantation Key Players in China (2019-2020)
8.3 China Transplantation Market Size by Type (2015-2020)
8.4 China Transplantation Market Size by Application (2015-2020)
9 Japan
9.1 Japan Transplantation Market Size (2015-2020)
9.2 Transplantation Key Players in Japan (2019-2020)
9.3 Japan Transplantation Market Size by Type (2015-2020)
9.4 Japan Transplantation Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Transplantation Market Size (2015-2020)
10.2 Transplantation Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Transplantation Market Size by Type (2015-2020)
10.4 Southeast Asia Transplantation Market Size by Application (2015-2020)
11 India
11.1 India Transplantation Market Size (2015-2020)
11.2 Transplantation Key Players in India (2019-2020)
11.3 India Transplantation Market Size by Type (2015-2020)
11.4 India Transplantation Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Transplantation Market Size (2015-2020)
12.2 Transplantation Key Players in Central & South America (2019-2020)
12.3 Central & South America Transplantation Market Size by Type (2015-2020)
12.4 Central & South America Transplantation Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview
13.1.3 AbbVie Transplantation Introduction
13.1.4 AbbVie Revenue in Transplantation Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Arthrex
13.2.1 Arthrex Company Details
13.2.2 Arthrex Business Overview
13.2.3 Arthrex Transplantation Introduction
13.2.4 Arthrex Revenue in Transplantation Business (2015-2020)
13.2.5 Arthrex Recent Development
13.3 Zimmer Biomet
13.3.1 Zimmer Biomet Company Details
13.3.2 Zimmer Biomet Business Overview
13.3.3 Zimmer Biomet Transplantation Introduction
13.3.4 Zimmer Biomet Revenue in Transplantation Business (2015-2020)
13.3.5 Zimmer Biomet Recent Development
13.4 Medtronic
13.4.1 Medtronic Company Details
13.4.2 Medtronic Business Overview
13.4.3 Medtronic Transplantation Introduction
13.4.4 Medtronic Revenue in Transplantation Business (2015-2020)
13.4.5 Medtronic Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Transplantation Introduction
13.5.4 Novartis Revenue in Transplantation Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Stryker
13.6.1 Stryker Company Details
13.6.2 Stryker Business Overview
13.6.3 Stryker Transplantation Introduction
13.6.4 Stryker Revenue in Transplantation Business (2015-2020)
13.6.5 Stryker Recent Development
13.7 BioLifeSolutions
13.7.1 BioLifeSolutions Company Details
13.7.2 BioLifeSolutions Business Overview
13.7.3 BioLifeSolutions Transplantation Introduction
13.7.4 BioLifeSolutions Revenue in Transplantation Business (2015-2020)
13.7.5 BioLifeSolutions Recent Development
13.8 Teva Pharmaceuticals
13.8.1 Teva Pharmaceuticals Company Details
13.8.2 Teva Pharmaceuticals Business Overview
13.8.3 Teva Pharmaceuticals Transplantation Introduction
13.8.4 Teva Pharmaceuticals Revenue in Transplantation Business (2015-2020)
13.8.5 Teva Pharmaceuticals Recent Development
13.9 Veloxis Pharmaceuticals
13.9.1 Veloxis Pharmaceuticals Company Details
13.9.2 Veloxis Pharmaceuticals Business Overview
13.9.3 Veloxis Pharmaceuticals Transplantation Introduction
13.9.4 Veloxis Pharmaceuticals Revenue in Transplantation Business (2015-2020)
13.9.5 Veloxis Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Transplantation Key Market Segments
Table 2. Key Players Covered: Ranking by Transplantation Revenue
Table 3. Ranking of Global Top Transplantation Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Transplantation Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Kidney Transplantation
Table 6. Key Players of Liver Transplantation
Table 7. Key Players of Heart Transplantation
Table 8. Key Players of Lung Transplantation
Table 9. Key Players of Pancreas Transplantation
Table 10. Global Transplantation Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Transplantation Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Transplantation Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Transplantation Market Share by Regions (2015-2020)
Table 14. Global Transplantation Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Transplantation Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Transplantation Market Growth Strategy
Table 20. Main Points Interviewed from Key Transplantation Players
Table 21. Global Transplantation Revenue by Players (2015-2020) (Million US$)
Table 22. Global Transplantation Market Share by Players (2015-2020)
Table 23. Global Top Transplantation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transplantation as of 2019)
Table 24. Global Transplantation by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Transplantation Product Solution and Service
Table 27. Date of Enter into Transplantation Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Transplantation Market Size by Type (2015-2020) (Million US$)
Table 30. Global Transplantation Market Size Share by Type (2015-2020)
Table 31. Global Transplantation Revenue Market Share by Type (2021-2026)
Table 32. Global Transplantation Market Size Share by Application (2015-2020)
Table 33. Global Transplantation Market Size by Application (2015-2020) (Million US$)
Table 34. Global Transplantation Market Size Share by Application (2021-2026)
Table 35. North America Key Players Transplantation Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Transplantation Market Share (2019-2020)
Table 37. North America Transplantation Market Size by Type (2015-2020) (Million US$)
Table 38. North America Transplantation Market Share by Type (2015-2020)
Table 39. North America Transplantation Market Size by Application (2015-2020) (Million US$)
Table 40. North America Transplantation Market Share by Application (2015-2020)
Table 41. Europe Key Players Transplantation Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Transplantation Market Share (2019-2020)
Table 43. Europe Transplantation Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Transplantation Market Share by Type (2015-2020)
Table 45. Europe Transplantation Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Transplantation Market Share by Application (2015-2020)
Table 47. China Key Players Transplantation Revenue (2019-2020) (Million US$)
Table 48. China Key Players Transplantation Market Share (2019-2020)
Table 49. China Transplantation Market Size by Type (2015-2020) (Million US$)
Table 50. China Transplantation Market Share by Type (2015-2020)
Table 51. China Transplantation Market Size by Application (2015-2020) (Million US$)
Table 52. China Transplantation Market Share by Application (2015-2020)
Table 53. Japan Key Players Transplantation Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Transplantation Market Share (2019-2020)
Table 55. Japan Transplantation Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Transplantation Market Share by Type (2015-2020)
Table 57. Japan Transplantation Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Transplantation Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Transplantation Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Transplantation Market Share (2019-2020)
Table 61. Southeast Asia Transplantation Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Transplantation Market Share by Type (2015-2020)
Table 63. Southeast Asia Transplantation Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Transplantation Market Share by Application (2015-2020)
Table 65. India Key Players Transplantation Revenue (2019-2020) (Million US$)
Table 66. India Key Players Transplantation Market Share (2019-2020)
Table 67. India Transplantation Market Size by Type (2015-2020) (Million US$)
Table 68. India Transplantation Market Share by Type (2015-2020)
Table 69. India Transplantation Market Size by Application (2015-2020) (Million US$)
Table 70. India Transplantation Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Transplantation Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Transplantation Market Share (2019-2020)
Table 73. Central & South America Transplantation Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Transplantation Market Share by Type (2015-2020)
Table 75. Central & South America Transplantation Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Transplantation Market Share by Application (2015-2020)
Table 77. AbbVie Company Details
Table 78. AbbVie Business Overview
Table 79. AbbVie Product
Table 80. AbbVie Revenue in Transplantation Business (2015-2020) (Million US$)
Table 81. AbbVie Recent Development
Table 82. Arthrex Company Details
Table 83. Arthrex Business Overview
Table 84. Arthrex Product
Table 85. Arthrex Revenue in Transplantation Business (2015-2020) (Million US$)
Table 86. Arthrex Recent Development
Table 87. Zimmer Biomet Company Details
Table 88. Zimmer Biomet Business Overview
Table 89. Zimmer Biomet Product
Table 90. Zimmer Biomet Revenue in Transplantation Business (2015-2020) (Million US$)
Table 91. Zimmer Biomet Recent Development
Table 92. Medtronic Company Details
Table 93. Medtronic Business Overview
Table 94. Medtronic Product
Table 95. Medtronic Revenue in Transplantation Business (2015-2020) (Million US$)
Table 96. Medtronic Recent Development
Table 97. Novartis Company Details
Table 98. Novartis Business Overview
Table 99. Novartis Product
Table 100. Novartis Revenue in Transplantation Business (2015-2020) (Million US$)
Table 101. Novartis Recent Development
Table 102. Stryker Company Details
Table 103. Stryker Business Overview
Table 104. Stryker Product
Table 105. Stryker Revenue in Transplantation Business (2015-2020) (Million US$)
Table 106. Stryker Recent Development
Table 107. BioLifeSolutions Company Details
Table 108. BioLifeSolutions Business Overview
Table 109. BioLifeSolutions Product
Table 110. BioLifeSolutions Revenue in Transplantation Business (2015-2020) (Million US$)
Table 111. BioLifeSolutions Recent Development
Table 112. Teva Pharmaceuticals Business Overview
Table 113. Teva Pharmaceuticals Product
Table 114. Teva Pharmaceuticals Company Details
Table 115. Teva Pharmaceuticals Revenue in Transplantation Business (2015-2020) (Million US$)
Table 116. Teva Pharmaceuticals Recent Development
Table 117. Veloxis Pharmaceuticals Company Details
Table 118. Veloxis Pharmaceuticals Business Overview
Table 119. Veloxis Pharmaceuticals Product
Table 120. Veloxis Pharmaceuticals Revenue in Transplantation Business (2015-2020) (Million US$)
Table 121. Veloxis Pharmaceuticals Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transplantation Market Share by Type: 2020 VS 2026
Figure 2. Kidney Transplantation Features
Figure 3. Liver Transplantation Features
Figure 4. Heart Transplantation Features
Figure 5. Lung Transplantation Features
Figure 6. Pancreas Transplantation Features
Figure 7. Global Transplantation Market Share by Application: 2020 VS 2026
Figure 8. Hospitals and Transplant Centers Case Studies
Figure 9. Diagnostic Registries and Research Laboratories Case Studies
Figure 10. Transplantation Report Years Considered
Figure 11. Global Transplantation Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Transplantation Market Share by Regions: 2020 VS 2026
Figure 13. Global Transplantation Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Transplantation Market Share by Players in 2019
Figure 16. Global Top Transplantation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transplantation as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Transplantation Revenue in 2019
Figure 18. North America Transplantation Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Transplantation Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Transplantation Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Transplantation Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Transplantation Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Transplantation Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Transplantation Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed